English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine Healthcare & Pharm
Novotech is Gold Sponsor at Biotech Showcase 2023
Dec 20, 2022 11:00 HKT
TANAKA Contributes to Venture Capital Fund "DMC No. 1 Investment Limited Partnership" Aiming to Establish a Medical Venture Ecosystem in Japan
Dec 20, 2022 10:00 HKT
Gelonghui Reports CMS' Successful Phase III Study of Methylthioninium Chloride Enteric-coated Sustained-release Tablets
Dec 19, 2022 19:00 HKT
SinoMab Awarded the "Most Valuable Pharmaceutical and Medical Company" in the Selection of the "7th Hong Kong Golden Stocks Awards"
Dec 19, 2022 14:55 HKT
An Integrated Biopharmaceutical Company Covering "R&D- Production-Commercialization" Boan Biotech's Global Offering of H Shares
Dec 19, 2022 10:25 HKT
Prenetics Acquires ACT Genomics; First M&A Deal since IPO, Set to Expand Footprint in Cancer Genomics
Dec 16, 2022 19:57 HKT
Data Shows 50% of New Trials Have Sites in Asia Pacific
Dec 15, 2022 10:00 HKT
Sirnaomics Announces Positive Interim Data from Phase IIb Clinical Trial of STP705 in Adults with Cutaneous Squamous Cell Carcinoma In Situ
Dec 14, 2022 23:15 HKT
Preventing Strokes and Heart Attacks Doesn't Have to Come with the Risk of Life-threatening Bleeding
Dec 14, 2022 21:45 HKT
EC Healthcare wins "Best in Healthcare Sector" at IR Magazine's Greater China Awards 2022
Dec 14, 2022 21:38 HKT
Sirnaomics Executive Director Dr. Xiaochang Dai to Deliver Keynote Speech at BIOHK2022
Dec 14, 2022 11:56 HKT
Major Global Medical Device Manufacturer OrbusNeich Medical Group Announces Details of Proposed Listing on the Main Board of HKEX
Dec 13, 2022 10:10 HKT
Polymer protection for vaccines and drugs
Dec 09, 2022 23:00 HKT
Led by Legend Capital, GS Biotech Completes Nearly CNY100 million Pre-A Round Financing
Dec 09, 2022 19:27 HKT
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing
Dec 06, 2022 14:00 HKT
Novotech Awarded the Asia Pacific CRO of the Year 2022 for Best Practices in Clinical Trials
Dec 06, 2022 11:00 HKT
Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index
Nov 30, 2022 22:43 HKT
Tianda Pharma Announces 2022/23 Interim Results
Nov 25, 2022 23:54 HKT
JBM Healthcare Announces FY2023 Interim Results
Nov 25, 2022 23:25 HKT
Jacobson Pharma Announces FY2023 Interim Results
Nov 25, 2022 21:21 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: